Archives jill-milne

by in
Entry Author Date Location
After Shift to Duchenne and Cholesterol Drugs, Catabasis Files For IPO 05/14/15 Boston
East Coast Biotech Roundup: Sarepta, Zalicus, Alkermes, & More 11/15/13 Boston
Catabasis Scores $32M Series B Round With IPO in Sight 11/15/13 Boston
Catabasis Passes First Trials With Anti-Inflammatory Drug 02/11/13 Boston
Catabasis Begins Human Trials of Omega-3-Inspired Diabetes Treatment 10/20/11 Boston
Catabasis, Led by Sirtris Vets, Seeks to Fight Diabetes by Controlling Inflammation 04/21/10 Boston
Catabasis Pharmaceuticals Pockets $7.7M out of $40M Venture Round 04/15/10 Boston
Page 1 of 1